Dynamic PET (dPET) studies have been used until now primarily within research purposes.
Although it is generally accepted that the information provided by dPET is superior to that of …

Over the past decades, a variety of PET tracers have been used for the evaluation of patients
with brain tumors. For clinical routine, the most important clinical indications for PET imaging …

Routine diagnostics and treatment monitoring of brain tumors is usually based on contrast-
enhanced MRI. However, the capacity of conventional MRI to differentiate tumor tissue from …

A previous review published in 2012 demonstrated the role of clinical PET for diagnosis and
management of brain tumors using mainly FDG, amino acid tracers, and 18 F …

Although rare, glioblastomas account for the majority of primary brain lesions, with a
dreadful prognosis. Magnetic resonance imaging (MRI) is currently the imaging method …

Imaging plays a critical role in the management of the highly complex and widely diverse
central nervous system (CNS) malignancies in providing an accurate diagnosis, treatment …

Contrast-enhanced magnetic resonance imaging is currently the standard of care in the
management of primary brain tumors, although certain limitations remain. Metabolic imaging …

Amino-acid PET imaging is an efficient complementary tool to MRI for the assessment of
gliomas, principally for high-grade gliomas [1] and is now recommended by the Response …

Immunotherapies that employ immune checkpoint modulators (ICMs) have emerged as an
effective treatment for a variety of solid cancers, as well as a paradigm shift in the treatment …

Brain neoplasms constitute a group of tumors with discrete differentiation grades, and
therefore, course of disease and prognosis. Magnetic resonance imaging (MRI) remains the …